KBTBD6 divergent transcript (KBTBD6-DT)

KBTBD6 divergent transcript (KBTBD6-DT, also called AL354696.2) is a predicted long non-coding RNA (lncRNA) gene found at the KBTBD6 locus in the human genome. Unlike KBTBD6, which encodes a protein component of the CUL3-based E3 ubiquitin ligase complex[1][3], KBTBD6-DT does not code for a known protein product and has no established biological function, disease association, or indication as a therapeutic target. Current resources do not support a biological role or clinical relevance for KBTBD6-DT and there are no known drug interactions, biomarkers, or safety considerations associated with this transcript[5]. KBTBD6-DT is distinct from the KBTBD6 protein-coding gene, which is functionally characterized as part of protein degradation pathways[1][3]. The designation "divergent transcript" or "-DT" typically refers to a transcript running in the opposite direction from a known coding gene; often these are non-coding. There are no literature reports of disease association, role in signaling, or pharmacological targeting. Information about KBTBD6-DT is mainly limited to genomic annotations, with minimal experimental data or functional insight[5]. If you intended the protein-coding KBTBD6 gene, please clarify, as that gene is better characterized, with defined biological functions and molecular interactions[1][3]. However, based on current evidence, KBTBD6-DT is not recognized as a disease or drug target.

Other names

AL354696.2KBTBD6-DT

None